指南与共识神经儿科影像MR

新生儿脑病的磁共振成像与波谱:当前共识立场与未来机遇

Magnetic resonance imaging and spectroscopy in neonatal encephalopathy: current consensus position and future opportunities.
指南 / 共识 · Pediatr Res · 2025-10-03

本文为新生儿脑病(NE)的MRI与1H-MRS应用共识,指出MRI是表征NE相关脑损伤的金标准,DWI可早期检出损伤,基底节与丘脑的Lac/NAA峰面积比是两年神经发育结局的稳健预后指标;多模态MRI评分系统与后期神经发育结局相关性好;标准化采集与后处理可使MRI生物标志物作为神经保护试验的早期替代终点,从而减小样本量并加速临床转化。

要点

  • MRI是表征新生儿脑病相关脑损伤的金标准。
  • 基底节与丘脑的Lac/NAA峰面积比可稳健预测两年神经发育结局。
  • 多模态MRI评分系统与后期神经发育结局相关性好。

核心结论

  • MRI与1H-MRS整合可增强预后判断、指导临床管理并支持新生儿脑病诊疗中的知情决策。

研究设计与样本

  • 本文为新生儿脑病MRI与MRS应用的共识立场文件,由Pediatr Res发表。
  • 原文未报告样本量、中心数及具体设备/序列参数。

关键影像表现/征象

  • DWI可早期检出新生儿脑病相关脑损伤。
  • 基底节与丘脑的Lac/NAA峰面积比可提供两年神经发育结局的稳健预后指标。
  • DTI、ASL和BOLD成像可进一步反映微结构完整性、灌注和功能连接。

诊断标准与关键数值

  • 原文以基底节与丘脑的Lac/NAA峰面积比作为两年神经发育结局的预后指标,未报告具体阈值。
  • 原文提及多模态MRI评分系统与后期神经发育结局相关性好,未报告具体评分标准及数值。

临床应用与阅片要点

  • 作者强调优化采集协议、准确解读并使用MRI评分系统以增强临床决策。
  • 标准化采集与后处理可使MRI生物标志物作为神经保护试验的可靠早期替代终点,从而减小样本量并加速临床转化。

局限性

  • 原文指出当前存在局限性并讨论了未来方向,但未逐条列出具体局限内容。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

Neonatal encephalopathy (NE) is a significant global health concern. It is a leading cause of long-term neurodevelopmental impairment, with hypoxic-ischaemic perinatal brain injury being the most common underlying contributor. Although therapeutic hypothermia has reduced mortality and improved outcomes for some affected infants, many survivors experience neurodevelopmental disability, including cerebral palsy and/or deficits in cognition, behaviour, and executive functioning. Early and accurate prognostication and identification of injury severity remain a challenge due to evolving clinical signs and multiple etiologies. Magnetic resonance imaging (MRI) is the gold standard for characterizing NE-related brain injury. Diffusion-weighted imaging (DWI) enables early detection of injury, and proton magnetic resonance spectroscopy (1H-MRS), specifically the Lac/NAA peak area ratio from basal ganglia and thalamus, provides robust prognostic indicators of two-year neurodevelopmental outcomes. MRI scoring systems incorporating multiple modalities correlate well with later neurodevelopmental outcomes. Advanced imaging modalities, such as diffusion tensor imaging (DTI), arterial spin labelling (ASL), and blood oxygen level-dependent (BOLD) imaging, offer further insights into microstructural integrity, perfusion, and functional connectivity. By standardizing acquisition protocols and post-processing, MRI biomarkers can serve as reliable, early surrogate endpoints in neuroprotection trials, allowing smaller sample sizes and accelerating clinical translation. MRI and 1H-MRS integration enhances prognostication, guides clinical management, and supports informed decision-making in NE care. IMPACT: This article highlights the importance of state-of-the-art MRI and MRS techniques for assessing neonatal encephalopathy (NE), emphasizing optimized protocols, accurate interpretation, and the use of MRI scoring systems to enhance clinical decision-making. It provides a comprehensive guide to advanced MRI/MRS acquisition and interpretation in neonates with NE, addressing current limitations and future directions. By optimizing neonatal MRI/MRS practices, this work aims to improve early diagnosis and prognostication, guide treatment strategies, and ultimately improve the management of neonates with NE.

来源:Pediatr Res,查看原文。版权归原作者所有。

引用

  1. Laptook A, Garvey AA, Adams C, et al. Magnetic resonance imaging and spectroscopy in neonatal encephalopathy: current consensus position and future opportunities. Pediatr Res. 2025. PMID: 41044228. doi:10.1038/s41390-025-04448-5

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。